Core Viewpoint - The company, Entropy Technology (301330.SZ), clarified that its products related to Longzhiyuan do not involve the military industry, focusing instead on brain-machine technology applications in education, healthcare, and elderly care [1]. Group 1 - The company confirmed that its products are not related to the military sector [1] - The primary application areas for the company's brain-machine technology are education, healthcare, and elderly care [1]

Group 1 - The core viewpoint of the article is that Entropy Technology (301330) clarified that its acquisition of Longzhiyuan Company does not involve the military industry, focusing instead on brain-machine technology applications in education, healthcare, and elderly care [1]

Core Viewpoint - Entropy Technology (301330.SZ) has announced the acquisition of 55% equity in Shenzhen Longzhiyuan Technology Co., Ltd. for RMB 416.35 million, marking a strategic expansion for the company [1] Group 1: Acquisition Details - The company approved the acquisition during the 22nd meeting of its third board of directors held on October 17, 2025 [1] - The acquisition involves purchasing shares from multiple shareholders, including Yu Mengchu, Li Weihua, and others [1] - Following the acquisition, Longzhiyuan will change from a joint-stock company to a limited liability company, which is a prerequisite for the transaction [1] Group 2: Corporate Changes - Longzhiyuan has completed the necessary business registration changes and has been renamed Shenzhen Longzhiyuan Technology Co., Ltd. [1] - After the completion of the business registration, Longzhiyuan will become a subsidiary of the company and will be included in the company's consolidated financial statements [1]

证券代码：301330 证券简称：熵基科技 公告编号：2025-096 熵基科技股份有限公司 关于收购深圳市龙之源科技股份有限公司 55%股权 事项进展暨完成工商变更登记的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 一、交易概述 1、公司名称：深圳市龙之源科技有限公司 2、统一社会信用代码：91440300786581790N 3、认缴注册资本（万元）：3,023.103 2025 年 5 月 12 日，熵基科技股份有限公司（以下简称"公司"）因筹划通 过支付现金收购禹孟初、李伟华、深圳乘天企业管理有限公司（以下简称"乘天 有限"）、深圳市龙鼎兴企业管理合伙企业（有限合伙）（以下简称"龙鼎兴"）、 深圳龙聚鑫投资合伙企业（有限合伙）（以下简称"龙聚鑫"）、深圳龙合鑫投资 合伙企业（有限合伙）（以下简称"龙合鑫"）、深圳龙溢鑫投资合伙企业（有限 合伙）（以下简称"龙溢鑫"）、深圳沃龙汇投资合伙企业（有限合伙）（以下简称 "沃龙汇"）、李伟雄合计持有的深圳市龙之源科技股份有限公司（以下简称"龙 之源"）55%股权并取得龙之源的控股权事项，与龙之源及上述龙之源 ...

Core Viewpoint - The company focuses on brain-machine interface technology with applications in education, healthcare, and elderly care, utilizing AI-driven multimodal data fusion technology for product development [1] Group 1: Business Focus - The company is developing products in three main areas: analysis and diagnosis, detection-assisted rehabilitation, and treatment [1] - In the field of smart education, the company integrates brain-machine interface technology with interactive games to enhance students' concentration [1] Group 2: Product Development Timeline - The brain-machine business is expected to launch a prototype by March 2026 [1] Group 3: Strategic Partnerships - The company has formed a strategic partnership with NeuroSky, a leader in non-invasive brain-machine interface technology, to establish a joint venture [1] - The collaboration aims to create an innovative framework combining "chip + emotion cloud + industrial ecosystem" to accelerate the global strategic layout of brain-machine interface technology [1]

Core Viewpoint - The company, Entropy Technology (301330.SZ), is focused on advancing brain-computer interaction technology through its subsidiary, Entropy Cloud Brain Technology, in the fields of multimodal BioCV and AIoT [1] Group 1: Technology and Innovation - The company has developed an integrated ecosystem of "hardware + software + services" in the areas of iris recognition, eye tracking, and EEG analysis algorithms [1] - At a global conference in Thailand, the company showcased a product matrix of brain-machine innovation, including brain rings, brain-controlled drones, EEG safety helmets, and attention enhancement systems [1] - These innovations provide mature hardware carriers and service capabilities for the practical application of technology [1]

Core Viewpoint - The company, Entropy Technology (301330.SZ), is pursuing a strategy that combines both organic growth and external development through acquisitions [1] Group 1: Acquisition Strategy - The acquisition of Longzhiyuan marks the company's first acquisition project since its listing [1] - The company plans to continue seeking other projects that can empower its growth through investments or acquisitions [1] Group 2: Shareholding and Financial Impact - On October 17, the company announced the signing of a "Letter of Intent for Acquisition" with Longzhiyuan, with the shareholding change expected to be completed by the end of November [1] - Upon completion of the shareholding change, Entropy Technology will hold 55% of Longzhiyuan's shares and will consolidate its financial statements [1]

Core Viewpoint - Entropy Technology (301330) is actively pursuing strategic acquisitions and expanding its brain-computer interface (BCI) technology, focusing on education, healthcare, and elderly care applications, while maintaining a strong cash flow and exploring further investment opportunities [2][3][4]. Group 1: Acquisition and Financial Performance - Entropy Technology signed a "Letter of Intent" with Longzhiyuan on October 17, 2025, to acquire a 55% stake, with completion expected by the end of November [2]. - For the first three quarters of 2025, the company reported a main revenue of 1.401 billion yuan, a year-on-year decrease of 0.68%, while net profit attributable to shareholders increased by 6.24% to 128 million yuan [7]. Group 2: Brain-Computer Interface Development - The company is focusing on BCI technology in three core application areas: education, healthcare, and elderly care, utilizing multi-modal data fusion technology for product development [3]. - A prototype for the BCI business is expected to be launched by March 2026, and a strategic partnership with NeuroSky has been established to enhance BCI and multi-modal biometric technology integration [3]. Group 3: Market Position and Strategy - The BCI business overlaps with existing clients in healthcare and education, while also targeting new customer segments in consumer electronics, industry, and research [5]. - The company emphasizes a dual strategy of organic growth and external development, with the acquisition of Longzhiyuan being its first since going public [4].

Company Overview - Entropy Technology Co., Ltd. was established in 2007, focusing on cognitive-driven intelligent space evolution as a global leader in AI services [2] - The company utilizes multi-modal BioCV (computer vision and biometrics) and cognitive space computing technology to create a comprehensive perception system, transitioning from static management to autonomous decision-making and evolution [2] Strategic Areas - The company is deeply engaged in four strategic areas: smart space, smart office, digital identity authentication, and smart business, providing AI-enabled integrated solutions [2] - The acquisition of a 55% stake in Longzhiyuan is expected to broaden the company's smart living business into outdoor areas, enhancing the product array in smart outdoor scenarios [2][3] Brain-Computer Interface (BCI) Development - The company is focusing on three core application scenarios for BCI technology: education, healthcare, and elderly care, leveraging AI-driven multi-modal data fusion technology [4] - A prototype for the BCI business is expected to be launched by March 2026, with a strategic partnership established with NeuroSky to enhance BCI technology integration [4] Financial Strategy - The company maintains a dual strategy of organic growth and external development, with the acquisition of Longzhiyuan being the first since its listing [5] - Future investments or acquisitions will be pursued to enhance company value [5] Customer Overlap and Market Expansion - The BCI business overlaps with existing clients primarily in the healthcare and education sectors, while also targeting new customer groups in consumer electronics, industry, and research [6] - The company has established a comprehensive ecosystem in multi-modal BioCV and AIoT, showcasing innovative BCI products at global events [7]

Core Insights - Entropy Technology (301330) has announced a strategic partnership with NeuroSky to establish a joint venture focused on integrating "chip + emotion cloud + industrial ecosystem" in the field of brain-computer interfaces and multimodal biometric recognition [1][2] - The collaboration aims to leverage both companies' technological strengths in multimodal BioCV, AI cognition, and brain-computer interface technologies, creating a complete innovation chain from core chips to algorithm platforms and application scenarios [1][2] Company Overview - NeuroSky is a leading player in the non-invasive brain-computer interface chip market, holding a significant market share and achieving breakthroughs in consumer-grade brainwave monitoring [1] - The company has developed the TGAM series dry electrode brainwave chips, which facilitate "plug-and-play" brainwave detection, lowering the barriers to brain-computer interface technology [1] - NeuroSky's innovations include the world's smallest electrocardiogram sensor, enabling widespread applications in emotion, fatigue, and sleep monitoring [1] Product Development - Entropy Technology has been focusing on multimodal BioCV and AIoT, creating an integrated ecosystem of "hardware + software + services" through its subsidiary, Entropy Brain Technology [2] - Recent product launches include brain rings, brain-controlled drones, brainwave safety helmets, and attention enhancement systems, providing mature hardware and service capabilities for technology implementation [2] Innovation Focus - The partnership will concentrate on two main areas: developing next-generation edge brain-computer interface algorithm chips that integrate various emotional and behavioral algorithms, and advancing mixed biometric recognition and brain signal collaborative analysis [2] - The emotional recognition capabilities will cover three core dimensions: optimistic emotions, negative emotions, and behavioral emotions, enabling detailed identification of fatigue, anxiety, stress, relaxation, happiness, alertness, and empathy [2] Vision and Goals - The chairman of Entropy Technology emphasized the company's commitment to a harmonious coexistence of technology and humanity, aiming to create a new era of emotional perception intelligence through the collaboration with NeuroSky [2] - NeuroSky's CEO highlighted the alignment of both companies' missions to promote the widespread application of brain-computer interface technology, aiming to enhance user experiences in safety management, health, and productivity [2]